Literature DB >> 10605760

Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women.

K K Koh1, M K Horne, R O Cannon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10605760

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  6 in total

Review 1.  Postmenopausal hormone replacement therapy and atherosclerosis.

Authors:  Jennifer E Ho; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women.

Authors:  Kwang Kon Koh
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 3.  Hormone replacement therapy in the prevention and treatment of atherosclerosis.

Authors:  L Mosca
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

4.  The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.

Authors:  Marie Hudson; Andrée-Laure Herr; Joyce Rauch; Carolyn Neville; Erika Chang; Reda Ibrahim; Chantal Séguin; Jeannine Kassis; Lambert Busque; Paul R Fortin
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

5.  Triclosan causes spontaneous abortion accompanied by decline of estrogen sulfotransferase activity in humans and mice.

Authors:  Xiaoli Wang; Xiaojiao Chen; Xuejiao Feng; Fei Chang; Minjian Chen; Yankai Xia; Ling Chen
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

6.  Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative.

Authors:  Mary Cushman; Joseph C Larson; Frits R Rosendaal; Susan R Heckbert; J David Curb; Lawrence S Phillips; Alison E Baird; Charles B Eaton; Randall S Stafford
Journal:  Res Pract Thromb Haemost       Date:  2018-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.